Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocytes (CIK) against epithelial ovarian cancers, focus...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., Valabrega, G.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160190/
https://ncbi.nlm.nih.gov/pubmed/32296104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63634-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares